GFAP was identified as a highly susceptible substrate of PAD2 [21], and abnormal accumulation of citrullinated GFAP (cit-GFAP) was found in neurodegenerative diseases, including Alzheimer’s disease and prion disease [15, 21, 22]. This evidence concerns the gene GFAP and prion disease.